This global research hub leverages the power of a decentralized autonomous organization
(DAO) to connect researchers, funders, industry experts and any individuals who are
passionate about peptides, to accelerate peptide discoveries and bring life-changing
products to market faster and more efficiently than traditional methods. Despite the
presence of over 7,000 peptides in the human body, only 200 are in clinical development,
leaving vast potential untapped.
While the peptide therapeutics market is projected to exceed $117 billion by 2034, research
and investment remain heavily concentrated on metabolic peptides, such as GLP-1 receptor
agonists, which are projected to dominate 58% of the market in 2034. This leaves many
promising therapeutic areas, such as cancer, autoimmune diseases, neurodegenerative
disorders or cardiovascular disease, as well as the application of peptides for health
optimization and longevity, underfunded.